Velocity Clinical Research 1130 Upper Front St Bureau 928 m² À vendre Binghamton, NY 13905 2 251 905 € (2 427,81 €/m²) Taux de capitalisation 7,75 %

Available as a Portfolio or Individually
SAB Capital is pleased to present a prime investment opportunity: the fee-simple acquisition of three single-tenant R&D/Lab facilities operated and guaranteed by Velocity Clinical Research. These properties, available individually or as a portfolio, offer stable, long-term cash flow with minimal landlord responsibilities.
The offering includes three strategically located facilities:
Savannah, GA – 6,880 SF on 0.14 acres
Binghamton, NY – 9,984 SF on 1.48 acres
Norfolk, NE – 11,008 SF on 2.48 acres
Each property is ideally positioned along key regional thoroughfares, ensuring accessibility and high traffic.
The Tenant, Velocity Clinical Research, is a global leader in clinical trials, providing innovative solutions for pharmaceutical and biotech companies. With a network of 90+ sites and 220+ investigators across the U.S. and Europe, Velocity is one of the most rapidly growing research organizations in the industry. The company ranked #543 on the 2023 Inc. 5000 list, demonstrating its exceptional growth trajectory.
This portfolio represents a rare opportunity to acquire stabilized, net-leased assets in a high-demand industry with strong fundamentals. Investors seeking secure, long-term cash flow with rental growth will find this an exceptional addition to their portfolio.